Archive for October 2013

Nemlekar P, Shepherd M*, Lawson K, and Rush S. Web-Based Survey to Assess the Perceptions of Managed Care Organization Representatives on Use of Copay Subsidy Coupons for Prescription Drugs. J Manag Care Pharm. 2013;19(8):602-08.

ABSTRACT BACKGROUND: Promotion of prescription drug coupons and vouchers by pharmaceutical manufacturers has increased in recent years. These coupons and vouchers usually subsidize patients’ cost-sharing obligations. In other words, drug companies pay for a patient’s portion of the drug cost, and the remaining cost is paid by the patient and the patient’s health plan. This…

[...]

Florida Man Sent to Prison for 2 Years for Selling Unapproved Imported Cancer Medication

A Florida resident, Martin Paul Bean III has been sentenced to 2 years in prison in a complex counterfeit cancer drug scheme that purchased bulk cancer medications from Pakistan, India, and Turkey. The misbranded oncology drugs were then repackaged and sold as genuine, FDA-approved medications to medical practices throughout the United States. Repackaging work was…

[...]

Will the PSM 2013 Interchange Still Happen During the Government Shutdown?

You can count on it. The criminals who counterfeit drugs and endanger American patients haven’t stopped making and selling fake drugs during the shutdown. There is more need for a counterfeit drug conference now than ever. The 2013 Interchange will include: Patient advocates who represent patients whose lives depend on getting genuine medication Journalists who…

[...]

New Research on Threats to the Secure Drug Supply Chain at 2013 Interchange

2013 Interchange will feature new research from Carl L. Alsberg Fellow, Tim K. Mackey, and in-progress research from PSM Board member Marv Shepherd. As part of the Partnership for Safe Medicines continuing effort to inform the both the public and medical professionals about the dangers of counterfeit medication, we’re presenting two new research studies on…

[...]

Keynote Speaker Announced for Counterfeit Drug Conference

The Partnership for Safe Medicines is pleased to announce Deputy Director Ilisa Bernstein as the keynote speaker of the 2013 Interchange on October 24, in Washington, DC. Dr. Ilisa Bernstein is the Deputy Director of Office of Compliance in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA). She…

[...]